IN RE: GENERIC PHARMACEUTICALS PRICING ANTITRUST LITIGATION
This Document Relates to: In re: Clobetasol Cases All End-Payer And Indirect Reseller Actions In re: Digoxin Cases All End-Payer and Indirect Reseller Actions In re: Divalproex ER Cases All End-Payer and Indirect Reseller Actions In re: Doxycycline Cases All End-Payer and Indirect Reseller Actions In re: Econazole Cases All End-Payer and Indirect Reseller Actions In re: Pravastatin Cases All End-Payer and Indirect Reseller Actions
United States District Court, E.D. Pennsylvania.https://leagle.com/images/logo.png
Filed February 15, 2019.
Filed February 15, 2019.
Editors Note
Applicable Law: 15 U.S.C. § 1
Cause: 15 U.S.C. § 1 Antitrust Litigation
Nature of Suit: 410 Other Statutes: Anti - Trust Source: PACER
MCKESSON MEDICAL-SURGICAL, INC., Defendant, represented by ABRAM J. ELLIS , SIMPSON THACHER & BARTLETT LLP, PETER C. THOMAS , SIMPSON THACHER & BARTLETT LLP & SARA YOUNG RAZI , SIMPSON THACHER & BARTLETT LLP.
Defendants in this multidistrict antitrust litigation have moved to dismiss the state law claims by the End-Payer Plaintiffs ("EPPs") and the Indirect-Reseller Plaintiffs ("IRPs") with respect to the following generic drugs: (1) clobetasol; (2) digoxin;
Let's get started
Welcome to the leading source of independent legal reporting Sign on now to see your case. Or view more than 10 million decisions and orders.
Updated daily.
Uncompromising quality.
Complete, Accurate, Current.
Listed below are the cases that are cited in this Featured Case. Click the citation to see the full
text of the cited case. Citations are also linked in the body of the Featured Case.
Cited Cases
No Cases Found
Listed below are those cases in which this Featured Case is cited. Click on the case name to see the
full text of the citing case.